NEW YORK - s4story -- Rigani Press announces the release of the groundbreaking book Rushing Headlong: Health IT's Legacy and the Road to Responsible AI, by Dr. S. Yin Ho, a visionary who has founded and led health IT companies and initiatives over the past twenty-five years.

In this timely and provocative work, Dr. Ho explores why, even in an age swamped with digital information, it is still challenging for patients to access their own health data or find the right clinical trial, and for physicians to break free from constrictive, one-size-fits-all technology. Blending personal stories with unflinching industry analysis, Rushing Headlong reveals how conflicting economic incentives and regulatory inertia have left healthcare frustratingly fragmented.

More on S For Story

• Seth Neblett's Mothership Connected: Focuses on P-Funk's Women as Mothership Celebrates 50 Years
• At 25, She Became One of the Youngest AAPI Female Founders to Win One of the World's Most Prestigious Design Awards for a Lamp That Makes You Smile
• Nola Blue announces the forthcoming autobiography of Trudy Lynn
• Juego Studios Extends Full-Cycle Game Development & Outsourcing Capabilities to the UAE Market
• OurSeniors.net Magazine Marks 10 Years: Improving Senior Life with All-Inclusive Resources

The book is a must-read for anyone interested in technology, healthcare, and AI including physicians, patients, policymakers, C-level executives in health IT and clinical trial organizations, and healthcare AI entrepreneurs.

Rushing Headlong is not just another book about the promise of AI in healthcare.  It explains the complexity of the structure underlying the healthcare system as we know it has disappointed many, but for which a responsible approach to AI may change its course for the better.

Already receiving praise and endorsements from healthcare and technology leaders, Stéphane Bancel, CEO of Moderna writes: "Amid the noise of acceleration, Rushing Headlong reminds us that progress without purpose is peril. Its stories are urgent, universal, and deeply human– offering clarity for anyone determined not just to keep pace but to shape the future with intention."

Health tech economist J.D.Kleinke, author of many health, business and policy books including Oxymorons: The Myth of a U.S. Health Care System, provides an insightful foreword that puts the backdrop of this journey into perspective.

More on S For Story

• War, Peace, and Everything That Destroys You: The Novels of Leo Tolstoy, Reimagined
• VENUS Goes Live on CATEX Exchange As UK Financial Ltd Activates The Premier Division Of The Maya Meme's League
• NEW BOOK: Beyond Capitalism and Communism: The Case for Egalitarian Deliberative Democracy
• Digi 995: The Final Purge Ignites the Third Chapter of the Expanding Digiverse
• Atlanta Tech Founder Seeks Clarity on Intellectual Property and Innovation Policy

"Health IT was meant to bring innovation to patients and physicians and instead has been used to support healthcare transactions, increasing the gap between clinical care and clinical research, making it difficult to encourage a patient-centric healthcare system," notes Dr. Ho.

Rushing Headlong serves as an urgent call to action for thoughtful development of responsible AI for health IT with the purpose of creating a health system that returns agency to patients, physicians, and supports better research.

The book is available at Amazon and will be available at booksellers everywhere in January 2026.

#######

About S. Yin Ho, MD, MBA

S. Yin Ho, MD, MBA has spent more than two decades at the forefront of health information technology, clinical research, and digital health innovation. A Yale-trained emergency physician with an MBA from Harvard Business School, she has led health IT initiatives at Pfizer, Medidata, and Aetion. She founded the health economics analytics firm Context Matters (later acquired by Clarivate), and most recently served as interim CEO of Veradigm, where she spearheaded a key acquisition to develop health-specific generative AI models with electronic health records to support clinical research.